Mozzy_Valarte
Rising Star
I see many people claiming the use of maois/ssri's with serotonergic psychedelics gives this inherent risk regardless of dose, this simply is not the case. Inhibitors like Harmine, THH and Harmaline are dose sensitive compounds, so even with the possible risks, you won't get serotonin syndrome or the other associated risks as long as you start really small and work your way upwards. Furthermore a hippyflip is a commonly done combination with no inherent risks listed, even though Pcilocybin mushrooms contain maois themselves. and there's been studies on the concurrent administration of dxm with mdma which reduced the serotonin deficit gotten from mdma alone. there's been maois administered with amphetamine in a clinical setting for treatment resistant adhd patients (the study is on pubchem). and finally there's even been studies showing that when amphetamines like methamphetamine are metabolised quicker, the user will typically exhibit more adverse psychological reactions, with an increased rate of addiction. So from a technical standpoint the combination of maois with serotonergic psychedelics isn't inherently bad, however its extremely dose sensitive, meaning you'll be wanting to reduce your dose 75% and take into account for a longer duration aswell, though if done correctly it means your able to reduce your dose of the drug by a multitude of times (2-10x) depending on the bioavailability of the given compound
[NOTE: I am NOT advocating the use of pharmaceutical ssri drugs with psychedelics, if you are to experiment with enzyme inhibitors, you use something that is a plant or atleast derived from one, and you start VERY small due to the 2-10x multiplication]
[NOTE: I am NOT advocating the use of pharmaceutical ssri drugs with psychedelics, if you are to experiment with enzyme inhibitors, you use something that is a plant or atleast derived from one, and you start VERY small due to the 2-10x multiplication]